An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy

(2015) Grazia Arpino et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

(2015) P. J. Goodwin et al.   JNCI-Journal of the National Cancer Institute

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

(2015) P. J. Goodwin et al.   JNCI-Journal of the National Cancer Institute

Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

(2014) Derya Hopanci Bicakli et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Postdiagnosis C-Reactive Protein and Breast Cancer Survivorship: Findings from the WHEL Study

(2013) A. Villasenor et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory

(2013) Kirsten E. Bell et al.   CLINICAL NUTRITION

The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional study

(2013) Emer M Guinan et al.   Nutrition Journal

Comorbidity and survival of Danish breast cancer patients from 2000–2011: a population-based cohort study

(2013) Anne Ording et al.   Clinical Epidemiology

The impact of comorbidity on cancer survival: a review

(2013) Mette Sogaard et al.   Clinical Epidemiology

Changes in Weight and Body Composition in Women Receiving Chemotherapy for Breast Cancer

(2012) Mary Jo Nissen et al.   Clinical Breast Cancer

Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations

(2011) Pamela J. Goodwin et al.   JOURNAL OF CLINICAL ONCOLOGY

Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer

(2010) L.A. Healy et al.   CLINICAL ONCOLOGY

Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer

(2010) Catherine Duggan et al.   JOURNAL OF CLINICAL ONCOLOGY

Metabolic Syndrome and Elevated C-Reactive Protein in Breast Cancer Survivors on Adjuvant Hormone Therapy

(2010) Cynthia A. Thomson et al.   JOURNAL OF WOMENS HEALTH

The metabolic syndrome in cancer survivors

(2010) Esther C de Haas et al.   LANCET ONCOLOGY

Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors. Results of a single-center experience

(2009) Regina Gironés et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer

(2009) Geoffrey C. Kabat et al.   INTERNATIONAL JOURNAL OF CANCER

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients

(2009) Brandon L. Pierce et al.   JOURNAL OF CLINICAL ONCOLOGY

Adipose tissue as an endocrine organ

(2009) Sandra Galic et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case–control study

(2009) C. Agnoli et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Metabolic Syndrome Pandemic

(2008) Scott M. Grundy   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors

(2008) Brandon L. Pierce et al.   BREAST CANCER RESEARCH AND TREATMENT

High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome

(2008) Pamela J. Goodwin et al.   BREAST CANCER RESEARCH AND TREATMENT

Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer

(2008) Pamela J. Goodwin et al.   Clinical Breast Cancer